Affinity Asset Advisors »

Arcus Biosciences Incorporated shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Arcus Biosciences Incorporated (RCUS) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Arcus Biosciences Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Arcus Biosciences Incorporated held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcus Biosciences Incorporated by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $7.1M 300k 23.83

More positions owned by Affinity Asset Advisors

Spdr Series Trust State Street Spd Put Option (XBI)
Apogee Therapeutics (APGE)
Insmed Com Par $.01 (INSM)
Abivax Sa Sponsored Ads (ABVX)
Ishares Tr Ishares Biotech Call Option (IBB)
Ventyx Biosciences (VTYX)
Xenon Pharmaceuticals (XENE)
Praxis Precision Medicines I Com New (PRAX)
Cytokinetics Com New (CYTK)
Amgen (AMGN)
Spyre Therapeutics Com New (SYRE)
Wave Life Sciences SHS (WVE)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Select Sector Spdr Tr State Street Hea Call Option (XLV)
Roivant Sciences SHS (ROIV)

View all positions for Affinity Asset Advisors

Top funds holding Arcus Biosciences Incorporated

Gilead Sciences
BlackRock
Vanguard Group
Suvretta Capital Management
State Street Corporation
Woodline Partners
Marshall Wace
Point72 Asset Management
Siren
FMR
Fisher Investments
Caption Management
Geode Capital Management
Balyasny Asset Management
Bnp Paribas Investment Partners

View all funds holding Arcus Biosciences Incorporated